A TWO-PART STUDY TO INVESTIGATE THE DOSE-RANGING SAFETY AND PHARMACOKINETICS, FOLLOWED BY THE EFFICACY AND SAFETY OF ZX008 (FENFLURAMINE HYDROCHLORIDE) ORAL SOLUTION AS AN ADJUNCTIVE THERAPY IN CHILDREN ≥2 YEARS OLD AND YOUNG ADULTS WITH DRAVET SYNDROME: